Biopharmaceuticals β’ Pain β’ CNS β’ Narcolepsy β’ Major Depressive Disorder
201 - 500
π° $200M Post-IPO Equity on 2019-12
September 27
Biopharmaceuticals β’ Pain β’ CNS β’ Narcolepsy β’ Major Depressive Disorder
201 - 500
π° $200M Post-IPO Equity on 2019-12
β’ Axsome Therapeutics is seeking a Director, Field Access to oversee engagement strategies with healthcare providers. β’ This field-based role will oversee multiple time zones with both virtual and in-person leadership oversight, β’ Work cross-functionally to develop and implement strategies for effective access pull-through support across all regions. β’ Provide senior-level insights on national/regional payer policies, aiding the team in navigating payer issues. β’ High level vendor management and oversight for key vendor partners on access support. β’ Analyze trends in payer behavior and strategize accordingly with internal teams. β’ Build, lead, and coach a team of Field Access Managers in their engagement with healthcare providers. β’ Build and maintain high-level relationships with key accounts and stakeholders. β’ Stay ahead of significant market access, reimbursement, and policy developments. β’ Ensure the team is informed about changes in healthcare laws and reimbursement methodologies. β’ Partner with training and development team to build a managed access and patient services curriculum.
β’ 10+ years of industry experience with a minimum of 5 years' experience in leadership roles within Market Access, Payor Account Management, and/or Access Reimbursement β’ Comprehensive knowledge of payer policy, coverage and payment processes β’ Strong knowledge of compliance guidelines and principles related to Field Reimbursement teams and both their external and internal interactions β’ Demonstrated excellence in leadership and strategic roles β’ Ability to oversee a national team and key customer base, requiring travel throughout the United States when needed (30-50% travel), and use of technologies to successfully engage virtually
β’ Annual bonus β’ Significant equity β’ Generous benefits package
Apply NowSeptember 27
51 - 200
Oversee clinical studies for MindMed's brain health treatments.
πΊπΈ United States β Remote
π΅ $175k - $254.8k / year
π° $30M Post-IPO Equity on 2022-09
β° Full Time
π΄ Lead
π Director
September 27
201 - 500
Lead oncology market launch as Regional Business Director at Corcept.
πΊπΈ United States β Remote
π΅ $235k - $274k / year
π° $525.3k Post-IPO Equity on 2012-04
β° Full Time
π΄ Lead
π Director
π½ H1B Visa Sponsor
September 27
11 - 50
Directing healthcare transformation projects for Medicare and Medicaid sustainability.
September 27
501 - 1000
Lead and deliver complex engagements to improve manufacturing operations at Riveron.